You just read:

Amarantus Forms Subsidiaries "Elto Pharma" to Focus on CNS Disorders and "MANF Therapeutics" to Focus on Ophthalmology

News provided by

Amarantus BioScience Holdings, Inc.

Apr 17, 2017, 08:15 ET